- Home
- CAPT vs AADI Comparison
CAPT vs AADI Comparison
Compare CAPT & AADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- AADI
- Stock Information
- Founded
- CAPT 2005
- AADI 2011
- Country
- CAPT South Korea
- AADI United States
- Employees
- CAPT N/A
- AADI N/A
- Industry
- CAPT Blank Checks
- AADI Biotechnology: Pharmaceutical Preparations
- Sector
- CAPT Finance
- AADI Health Care
- Exchange
- CAPT Nasdaq
- AADI Nasdaq
- Market Cap
- CAPT 57.0M
- AADI 50.5M
- IPO Year
- CAPT N/A
- AADI N/A
- Fundamental
- Price
- CAPT $1.63
- AADI $2.15
- Analyst Decision
- CAPT
- AADI Hold
- Analyst Count
- CAPT 0
- AADI 3
- Target Price
- CAPT N/A
- AADI $1.75
- AVG Volume (30 Days)
- CAPT 105.4K
- AADI 116.7K
- Earning Date
- CAPT 01-01-0001
- AADI 11-06-2024
- Dividend Yield
- CAPT N/A
- AADI N/A
- EPS Growth
- CAPT N/A
- AADI N/A
- EPS
- CAPT N/A
- AADI N/A
- Revenue
- CAPT $17,389,944.00
- AADI $23,817,000.00
- Revenue This Year
- CAPT N/A
- AADI $4.79
- Revenue Next Year
- CAPT N/A
- AADI $10.72
- P/E Ratio
- CAPT N/A
- AADI N/A
- Revenue Growth
- CAPT 84.70
- AADI 10.57
- 52 Week Low
- CAPT $1.15
- AADI $1.21
- 52 Week High
- CAPT $12.00
- AADI $5.70
- Technical
- Relative Strength Index (RSI)
- CAPT 28.41
- AADI 70.67
- Support Level
- CAPT $1.92
- AADI $1.90
- Resistance Level
- CAPT $2.03
- AADI $2.19
- Average True Range (ATR)
- CAPT 0.14
- AADI 0.10
- MACD
- CAPT -0.05
- AADI 0.01
- Stochastic Oscillator
- CAPT 0.00
- AADI 86.89
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About AADI Aadi Bioscience Inc.
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.